ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

LIXT Lixte Biotechnology Holdings Inc

2.40
-0.12 (-4.76%)
Jun 14 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Lixte Biotechnology Holdings Inc LIXT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.12 -4.76% 2.40 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.51 2.37 3.50 2.45 2.52
more quote information »

Recent News

Date Time Source Heading
6/14/202411:00GLOBELIXTE Biotechnology Holdings announces collaboration on a..
6/14/202409:30GLOBELIXTE Biotechnology Holdings to Collaborate with Roche and..
6/06/202408:30GLOBEScientific Journal Reports Findings that Show LIXTE’s Lead..
6/03/202408:30GLOBELIXTE Biotechnology Holdings Names Distinguished Oncologist..
5/08/202409:25GLOBELIXTE Biotechnology Co-Sponsoring International Scientific..
4/24/202415:25APSMixed Shelf Filing Gives Micro Cap Delayed Boost
3/27/202415:35APSBiotech Steals The Show Following Pre-Clinical Data..
3/27/202408:30GLOBENEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD..
3/21/202408:30GLOBELIXTE Provides Update on Progress with LB-100 as a PP2A..
2/27/202416:59EDGAR2Form 8-K - Current report
2/27/202408:30GLOBEProfessor René Bernards to Present New Pre-Clinical Data on..
2/26/202410:48EDGAR2Form 8-K - Current report
2/26/202408:30GLOBELIXTE Biotechnology Enters into Exclusive Immune Oncology..
1/29/202408:30GLOBEFirst Patient Dosed with LIXTE’s LB-100 and GSK’s..
11/28/202317:21EDGAR2Form 8-K - Current report
11/13/202314:28EDGAR2Form 8-K - Current report
11/13/202308:30GLOBELIXTE Biotechnology Provides Update on Clinical Progress and..
11/09/202317:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/17/202317:27EDGAR2Form 8-K - Current report
10/16/202314:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/16/202308:30GLOBELIXTE, Netherlands Cancer Institute, and Oncode Institute to..
10/10/202315:55EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/10/202315:47EDGAR2Form DEF 14A - Other definitive proxy statements
10/09/202308:30GLOBELIXTE Biotechnology Holdings Announces the Passing of its..
10/05/202320:39EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
10/05/202320:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/04/202318:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/29/202316:05EDGAR2Form PRE 14A - Other preliminary proxy statements
9/27/202306:15EDGAR2Form 8-K - Current report
9/27/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/26/202308:30GLOBELIXTE Appoints Bas van der Baan as President and Chief..
9/20/202311:20EDGAR2Form 8-K - Current report
9/20/202308:30GLOBELIXTE Biotechnology Announces a Supported Collaborative..
8/11/202316:20EDGAR2Form S-3 - Registration statement under Securities Act of..
8/09/202308:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/21/202316:05EDGAR2Form 8-K - Current report
7/20/202316:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
7/20/202316:05GLOBELIXTE Biotechnology Announces Closing of $3.5 Million..
7/20/202311:45EDGAR2Form 8-K - Current report
7/18/202308:00GLOBELIXTE Biotechnology Announces Pricing of $3.5 Million..
7/17/202308:30GLOBEPreclinical Results of LIXTE Biotechnology’s Collaboration..
7/07/202314:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/07/202310:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/07/202310:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/07/202310:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/23/202308:30GLOBELIXTE Biotechnology Holdings, Inc. Regains Compliance with..

Your Recent History

Delayed Upgrade Clock